Legendary Actor William Shatner Backs Tinnitus Quest
LOS ANGELES, June 26, 2025 /PRNewswire/ --Tinnitus Quest, a newly established patient-led nonprofit committed to silencing tinnitus, today released a video message from iconic actor William Shatner, who has publicly endorsed the organization's mission and shared his personal decades long experience with the condition. William Shatner...
Youthful Narrative Bridges Traditional Chinese Medicine to Global Audience
LIAOCHENG, China, July 15, 2025 /PRNewswire/ -- Amidst global challenges in chronic disease prevention and health management, Traditional Chinese Medicine (TCM)'s core principles of "preventive treatment of disease" (zhi wei bing, 治未病) and "harmony between humanity and nature" (tian ren he yi, 天人合一) are gaining international attention. The TCM cultural program The Young TCM Masters, co-produced by Dong-E-E-Jiao Co.,...
NEL Animal Medical Foundation of Korea, Successfully Concludes Seminar for Nong Lam University Scholarship Recipients
HO CHI MINH CITY, Vietnam, Nov. 13, 2024 /PRNewswire/ -- The NEL Animal Medical Foundation of Korea announced that the seminar and scholarship award ceremony held at Nong Lam University on November 2nd was successfully concluded. A group photo after the seminar event inviting scholarship students from Nong Lam University The day before the scholarship award ceremony, a...
When ancient cures meet smart tech: Level up your health
BEIJING, Dec. 1, 2024 /PRNewswire/ -- This is a report from China.org.cn.  Join presenter Jason Dane Castleton at the Health and Wellness pavilion of the second China International Supply Chain Expo, where innovations from traditional medicine to genetic technology are transforming the industry. Join presenter Jason Dane Castleton at the Health and Wellness pavilion of the second...
Bon Announces Breakthrough Order for $16 Million Gut-Health Products
XI'AN, China, July 2, 2025 /PRNewswire/ -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), a leading bio-ingredient solutions provider in the natural, health, and personal care industries, today announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a leading wellness company in China ("Huahai Keyuan"). The term of the agreement is 24 months...
Watson-Marlow Fluid Technology Solutions focuses on BioClamp’s sustainability benefits and new WMArchitect Interchangeable Parts service at INTERPHEX Tokyo 2025
TOKYO, July 9, 2025 /PRNewswire/ -- Visitors to the Watson-Marlow Fluid Technology Solutions booth W15-2 at INTERPHEX Tokyo 2025 (July 9-11 at Tokyo Big Sight, Japan) can learn more about the new WMArchitect Interchangeable Parts service as well as how recently advanced manufacturing of BioClamp is bringing sustainability benefits to users. Steven Lin, Sales...
OSR Holdings Enters into Term Sheet to Acquire Woori IO, a Pioneer in Noninvasive Glucose Monitoring Technology
BELLEVUE, Wash. and SEOUL, South Korea, July 24, 2025 /PRNewswire/ -- OSR Holdings, Inc. (NASDAQ: OSRH), a global healthcare company advancing biomedical and wellness innovation, today announced it has signed a term sheet ("Term Sheet") with Woori IO Co., Ltd. ("WORIO"), a South Korean medical device company developing next-generation noninvasive glucose monitoring technology....
SO TECHAFRICA and Mindhyve.ai™ Forge Strategic Alliance to Advance Agentic AI for National Development in Nigeria
ABUJA, Nigeria and NEWPORT BEACH, Calif., July 31, 2025 /PRNewswire/ -- In a landmark collaboration aimed at accelerating innovation, capacity building, and digital transformation across Nigeria, SO TECHAFRICA LTD and U.S.-based Mindhyve.ai™ have signed a Memorandum of Understanding (MoU) to deploy agentic artificial intelligence (AI) in critical development sectors including education,...
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC
CHENGDU, China, Aug. 19, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) announced that clinical data from a Phase II study evaluating novel TROP2 antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) in combination with PD-L1 monoclonal antibody (mAb) tagitanlimab for the first-line treatment of advanced or metastatic non-small cell lung...
The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference Held in Chuxiong, Yunnan Province
CHUXIONG, China, Oct. 24, 2024 /PRNewswire/ -- The 2024 Seminar on International Communication of Chinese Medicine and Yi Medicine Big Health Industry Development Promotion Conference was held in Chuxiong, Yunnan Province on October 21. The event was co-sponsored by the China Association of Chinese Medicine, the China Center for International Communication Development of China International Communications Group (CICG), and the...
